Millennium Management

Millennium Management Portfolio holdings

AUM $139B
1-Year Est. Return 28.82%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+28.82%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$139B
AUM Growth
+$12.2B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,751
New
Increased
Reduced
Closed

Top Buys

1 +$4.75B
2 +$3.98B
3 +$1.42B
4
AVGO icon
Broadcom
AVGO
+$943M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$785M

Top Sells

1 +$572M
2 +$566M
3 +$554M
4
ABBV icon
AbbVie
ABBV
+$455M
5
BAC icon
Bank of America
BAC
+$411M

Sector Composition

1 Technology 16.28%
2 Healthcare 12.74%
3 Financials 11.54%
4 Industrials 10.46%
5 Consumer Discretionary 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAPP
1876
Rapport Therapeutics
RAPP
$1.33B
$6.12M ﹤0.01%
201,825
+47,651
E icon
1877
ENI
E
$75.5B
$6.12M ﹤0.01%
161,359
-28,924
TSSI
1878
TSS Inc
TSSI
$345M
$6.12M ﹤0.01%
865,350
+489,497
RXRX icon
1879
Recursion Pharmaceuticals
RXRX
$1.81B
$6.12M ﹤0.01%
+1,495,839
DMAC icon
1880
DiaMedica Therapeutics
DMAC
$379M
$6.12M ﹤0.01%
768,560
-418,749
ATMU icon
1881
Atmus Filtration Technologies
ATMU
$4.61B
$6.11M ﹤0.01%
117,797
-22,072
OSBC icon
1882
Old Second Bancorp
OSBC
$1.03B
$6.11M ﹤0.01%
+313,560
DNLI icon
1883
Denali Therapeutics
DNLI
$3.26B
$6.1M ﹤0.01%
369,767
-937,404
TRS icon
1884
TriMas Corp
TRS
$1.42B
$6.09M ﹤0.01%
171,719
+59,373
ACHC icon
1885
Acadia Healthcare
ACHC
$2.17B
$6.08M ﹤0.01%
428,304
+180,787
XMTR icon
1886
Xometry
XMTR
$1.91B
$6.08M ﹤0.01%
102,191
+68,721
GERN icon
1887
Geron
GERN
$1.01B
$6.08M ﹤0.01%
4,603,876
-6,764,113
GL icon
1888
Globe Life
GL
$10.9B
$6.07M ﹤0.01%
43,417
-314,449
UGP icon
1889
Ultrapar
UGP
$5.25B
$6.07M ﹤0.01%
1,610,338
-1,186,324
ABCL icon
1890
AbCellera Biologics
ABCL
$1.06B
$6.07M ﹤0.01%
1,773,539
-656,197
RYAM icon
1891
Rayonier Advanced Materials
RYAM
$757M
$6.06M ﹤0.01%
1,029,378
-330,374
VIR icon
1892
Vir Biotechnology
VIR
$1.48B
$6.05M ﹤0.01%
1,002,606
-393,898
SQM icon
1893
Sociedad Química y Minera de Chile
SQM
$21.3B
$6.04M ﹤0.01%
+87,806
MC icon
1894
Moelis & Co
MC
$3.8B
$6.04M ﹤0.01%
87,842
+2,113
TS icon
1895
Tenaris
TS
$26.7B
$6.01M ﹤0.01%
156,206
-418,217
FTK icon
1896
Flotek Industries
FTK
$531M
$6M ﹤0.01%
348,502
-460,896
VCTR icon
1897
Victory Capital Holdings
VCTR
$4.27B
$6M ﹤0.01%
95,104
+38,629
BLRKU
1898
Bluerock Acquisition Corp Unit
BLRKU
$6M ﹤0.01%
+600,000
CABA icon
1899
Cabaletta Bio
CABA
$295M
$5.99M ﹤0.01%
2,736,912
+2,050,099
CDRE icon
1900
Cadre Holdings
CDRE
$1.29B
$5.99M ﹤0.01%
146,657
+123,008